Johan Brink

• University of Gothenburg

The paper analyses the development of newly started bioscience firms in terms of their capabilities and changes in their business models. The study consists of eight retrospective case studies stemming from their foundation over a period of 5–15 years. Empirically the paper finds that all the firms quickly develop a technological capability at the...

This article analyses whether regions develop capabilities in terms of scientific, technological and business activities within specific biotechnology areas. We take a broad definition of biotechnology, and identify four industry areas: (1) core biotechnology; (2) drugs; (3) medical technologies; (4) agriculture. Capabilities and specialization-div...

A major research strand within strategic management research views the firm as composed of firm-specific capabilities that may result in competitive advantages and firm growth. Most empirical and theoretical research within capability based strategy research focuses on established firms with inherited capabilities and examines the process of gradua...

With the knowledge that cells can react to lithographically manufactured nanometer-sized surface objects, our interest concerned whether cells would respond to surface structures of systematically increasing size. Our approach to answer this question was to fabricate surfaces with the same surface chemistry and similar surface roughness but increas...

This paper addresses why biotech firms are struggling, especially whether firms active in different sub-sectors face different competitive conditions, analyzed in relation to indicators for competencies, knowledge networks and firm performance. The claim that we pursue is that the technological regimes differ in different sub-sectors. Because scien...